Tentang podcast ini
A weekly roundup of the latest news in rare disease.
The CheckRare Brief delivers a concise roundup of the week's most important developments in rare diseases. Each episode covers FDA approvals, clinical trial updates, conference highlights, scientific publications, and industry news that matter to healthcare professionals, researchers, advocates, and the rare disease community.
Produced by CheckRare, The CheckRare Brief helps you stay informed—in just a few minutes each week.
Episode
- Sanofi’s Orphan Drug Supply Update | Special Edition · 16 mnt · Musim 1 Episode 16On this special edition of the CheckRare Brief, we talk with Alaa Hamed, Sanofi's Global Head of Medical Affairs for Rare Diseases, and Maite Durrenbach, Head of Specialty Care…
- Highlights from The Liver Meeting 2026 · 9 mnt · Musim 1 Episode 15In this episode, we discuss highlights from The Liver Meeting, Ultragenyx program cuts, and ANI Pharmaceuticals’ offer to buy Egetis Therapeutics. Produced by CheckRare…
- 3D Printed Treatment Options · 9 mnt · Musim 1 Episode 14In this episode, we discuss a new formulation of treatment for HAE, the FDA approval of Voceryq for recurrent respiratory papillomatosis, and 3D printed treatment options…
- Gambling on Clinical Trials · 11 mnt · Musim 1 Episode 13In this episode, we discuss gambling on clinical trials, the FDA approval of a new formulation of Sjögren’s disease treatment, and an approval in IgA nephropathy. Produced by…
- Ultragenyx Gets $203M in Second Priority Review Voucher This Month · 12 mnt · Musim 1 Episode 12On this episode, we discuss the FDA approval of Enspryng for TED, the new FDA Rare Disease Framework Initiative, Ultrangenyx’s second sold PRV this month, and using AI to reduce…
- Ultragenyx Sells PRV for $210M · 9 mnt · Musim 1 Episode 11In this episode, we discuss Ultragenyx’s Priority Review Voucher that sold for $210 million, the efficacy of newborn screening on MLD, and ethical considerations needed to design…
- Therapies for MCT8 Deficiency and Nephrotic Syndrome Get FDA Approval · 9 mnt · Musim 1 Episode 10On September 28th, the FDA approved Emcitate, or tiratricol, from Egetis Therapeutics. It's the first-ever treatment for MCT8 deficiency, a condition also known as…
- New Rare Disease Center of Excellence and FDA Advances in Rare Disease · 10 mnt · Musim 1 Episode 9This week on The CheckRare Brief, we are joined by Eugene Lee, Head of CMI Media Group’s Rare Disease Division, for an industry perspective on some of the biggest developments in…
- FDA Approves New Therapies for MPS IIIA and SMA · 9 mnt · Musim 1 Episode 8The FDA announced the approval of Isembyld (apitegromab-mstn) to treat patients 2 yrs and older with spinal muscular atrophy who are currently receiving SMN2-targeted therapy…
- First-Line Therapy Approved for Rare Lung Cancer · 8 mnt · Musim 1 Episode 7This week, three developments highlight the rapidly changing rare disease treatment landscape: a Phase 3 setback in Angelman syndrome, continued competition in hereditary…
- FDA Approves Rare Disease Treatments as Huntington’s Gene Therapy Advances · 10 mnt · Musim 1 Episode 6In this episode of The CheckRare Brief, we discuss two recent FDA approvals for rare diseases, including Zanvastro for Alexander disease and Besremi for essential thrombocythemia…
- New FDA Approvals for Rare Diseases: From Autoimmune Disorders to Pancreatic Cancer · 9 mnt · Musim 1 Episode 5In this episode of The CheckRare Brief, we discuss four recent FDA approvals, including LISRAYA for dermatomyositis and Imaavy for warm autoimmune hemolytic anemia (wAIHA)…
- Getting a Rare Disease Drug Approved Is Only Half the Battle · 9 mnt · Musim 1 Episode 4FDA approval is a major milestone, but for patients with rare diseases, it is only the beginning. In this episode of The CheckRare Brief, we look at two new rare disease…
- FDA Approves Multiple Myeloma Drug; FDA Denies Neuroendocrine Drug; Safety Concerns For Prader-Willi Drug · 9 mnt · Musim 1 Episode 3On this week’s episode of The CheckRare Brief, we discuss FDA’s approval of Zenbexus (iberdomide) to treat patients with multiple myeloma, the complete response letter issued to…
- FDA Approves New Narcolepsy Treatment · 7 mnt · Musim 1 Episode 2On this week’s episode of The CheckRare Brief, we discuss FDA’s approval of Orzeyful (oveporexton) to treat patients with narcolepsy type 1, CAMP4’s first-in-human clinical trial…
- Episode 1: FDA Advisory Board’s Concerns About New Duchenne Drug, Brain Fog in Immune Thrombocytopenia; August is SMA Awareness Month · 7 mnt · Musim 1 Episode 1The CheckRare Brief delivers a concise summary of the week's most important developments in rare diseases. Each episode covers FDA approvals, clinical trial updates, conference…








